Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Goldman Sachs says AI hasn’t raised productivity across the economy, but two targeted use cases show a median 30% gai...
Netflix remains the benchmark in streaming, but rivals are accelerating with new pricing, ad tiers, and AI-driven fea...
Gemini Space Station stock dropped sharply after a downgrade spurred by profitability concerns and cautious guidance....
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
California Governor Gavin Newsom unveils a $350 billion budget designed to erase deficits, broaden reserves, and prot...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...
The June S&P 500 quarterly rebalance could see new entrants like Marvell Technology, Reddit, and a mortgage-focused s...
SpaceX is set to begin trading after a record $75 billion IPO, signaling strong appetite for space-enabled growth. Ma...
The April 2026 payout from a leading BDC ETF dropped to $0.71, signaling a broader shift that could leave income inve...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...